HeartWare HVAD System
Medtronic · Decision date Sep 23, 2026
What did the FDA approve?
The FDA recorded an approval decision on 2026-09-23 for P100047/S241, a Special (Immediate Track) supplement to the HeartWare® HVAD System premarket approval held by Medtronic. The device falls under the ventricular (assist) bypass category, cardiovascular specialty, product code DSQ. The supplement reason is listed as a labeling change covering indications, instructions, shelf life or tradename.
The recorded scope is limited to labeling: updates reflecting previously approved design changes, strengthened existing cybersecurity warnings, and editorial changes. This action does not constitute a new approval of the HVAD System as a whole, and the source record does not specify which labeling sections changed, the wording of the cybersecurity warnings, or the design changes referenced. No supporting documents were included, so those details remain unknown from this record.
FDA approval order statement
Approval for labeling updates to reflect previously approved design changes, strengthen existing cybersecurity warnings, and make editorial changes.
- Regulatory pathway
- PMA supplement
- Supplement type
- Special (Immediate Track)
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 23, 2026
- FDA change category
- Labeling Change - Indications/instructions/shelf life/tradename
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P100047/S241
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic
- Product code
- DSQ
- Decision code
- APPR
- Decision date
- Sep 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ventricular (assist) bypass.
For the original device and its historical approval scope, see PMA P100047. Subsequent supplements may change the device or its indications.
FDA decision timeline
P100047 · Original PMA
HEARTWARE VENTRICULAR ASSIST SYSTEM
P100047/S241 received
Application receipt date recorded by FDA.
P100047/S241 · FDA decision
Special (Immediate Track)
Timeline entries are records held by MedtechLedger for P100047. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P100047
Explore the linked device profile
Other records with product code DSQ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EXCOR Pediatric Ventricular Assist DeviceP160035/S054 | Berlin Heart, Inc. | PMA supplement | Oct 30, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S034 | Abbott | PMA supplement | Oct 30, 2026 | FDA |
EXCOR Pediatric VADP160035/S061 | Berlin Heart, Inc. | PMA supplement | Oct 28, 2026 | FDA |
EXCOR Pediatric Ventricular Assist DeviceP160035/S060 | Berlin Heart, Inc. | PMA supplement | Oct 23, 2026 | FDA |
HeartMate 3 Left Ventricular Assist SystemP160054/S136 | ABBOTT MEDICAL | PMA supplement | Oct 19, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. N.E, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P100047/S241
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


